1-11 of 11
Andy I. Chen, MD, PhD
Close
Sort by
Journal Articles

Updated Efficacy and Safety Data from the AETHERA Trial of Consolidation with Brentuximab Vedotin after Autologous Stem Cell Transplant (ASCT) in Hodgkin Lymphoma Patients at High Risk of Relapse

John Sweetenham, Jan Walewski, MDPhDProf, Auayporn P. Nademanee, MD, Tamas Masszi, Edward Agura, Jerzy Holowiecki, Muneer H. Abidi, MD, Andy I Chen, MD PhD, Patrick Stiff, Simonetta Viviani, MD, Angelo Michele Carella, Dzhelil Osmanov, Veronika Bachanova, MD, Anna Sureda, MD PhD, Dirk Huebner, Emily K Larsen, Naomi N Hunder, Craig H Moskowitz, MD
Journal: Blood
Blood (2015) 126 (23): 3172.
https://doi.org/10.1182/blood.V126.23.3172.3172
Published: 2015
Journal Articles

Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) for Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Preliminary Results of a Phase Ib Dose-Escalation

Nancy L. Bartlett, Andy I Chen, MD PhD, Kathryn S. Kolibaba, Thierry Lamy, MDPhD, Surai Jones, Jamie Hirata, Jeff P. Sharman, MD
Journal: Blood
Blood (2015) 126 (23): 2726.
https://doi.org/10.1182/blood.V126.23.2726.2726
Published: 2015
Journal Articles

Extramedullary Multiple Myeloma Associated With Reduced Overall Survival: A Retrospective Single-Center Study

Ido Barkay, MD, Richard T. Maziarz, MD, Andy I. Chen, MD, PhD, William Dibb, Yiyi Chen, PhD, Emma C. Scott, MD
Journal: Blood
Blood (2013) 122 (21): 5317.
https://doi.org/10.1182/blood.V122.21.5317.5317
Published: 2013
Journal Articles

Final Results Of a Phase I Study Of The Anti-CD22 Antibody-Drug Conjugate (ADC) DCDT2980S With Or Without Rituximab (RTX) In Patients (Pts) With Relapsed Or Refractory (R/R) B-Cell Non-Hodgkin’s Lymphoma (NHL)

Ranjana Advani, MD, Andy I. Chen, MD, PhD, Daniel Lebovic, MD, Mark W. Brunvand, MD, Andre Goy, MD, Julie E. Chang, MD, Ephraim Hochberg, Sreeni Yalamanchili, BSPharm, Robert Kahn, Dan Lu, Akiko Chai, MS, Yu-Waye Chu, Bruce D. Cheson, M.D.
Journal: Blood
Blood (2013) 122 (21): 4399.
https://doi.org/10.1182/blood.V122.21.4399.4399
Published: 2013
Journal Articles

Prognostic Features, Treatments, and Disease-Specific Mortality Among Patients with Diffuse Large B-Cell Lymphoma Over the Age of 75: A Single-Center Retrospective Analysis

Stephen D. Smith, MD, Craig Okada, MD, PhD, Andy I. Chen, MD, PhD, Stephen E Spurgeon, MD, Guang Fan, MD, PhD, Jennifer B Dunlap, MD, Nicky Leeborg, MD, Rita M. Braziel, MD, Richard T. Maziarz, MD
Journal: Blood
Blood (2012) 120 (21): 3673.
https://doi.org/10.1182/blood.V120.21.3673.3673
Published: 2012
Journal Articles

Outcomes of 252 Patients with High Risk Multiple Myeloma Treated with Hematopoietic Stem Cell Transplantation: Identification of Risk Factors Associated with Early Relapse, Shortened Progression Free and Overall Survival

Emma C. Scott, MD, Stephen D. Smith, MD, Andy I. Chen, MD, PhD, Nicky Leeborg, MD, Tarunpreet Bains, MD, Alex Stentz, BS, Rachel Frires, BA, William Dibb, James Dibb, Bryon Allen, NPP, Anne Kratz, RN, Racky Daffe, MS, Yiyi Chen, PhD, Richard T. Maziarz, MD
Journal: Blood
Blood (2012) 120 (21): 3957.
https://doi.org/10.1182/blood.V120.21.3957.3957
Published: 2012
Journal Articles

Safety of PK-Guided IV Bu Cy VP-16 Preparative Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Lymphoma: Findings From a Multi-Center Phase II Study in North America

Luciano J Costa, MD, PhD, Michael Lill, M.D., Rosa F. Yeh, PharmD, Robert K Stuart, MD, Stephen Lim, MD, Edmund K. Waller, MD, PhD, Tsiporah B. Shore, MD, Michael Craig, MD, Cesar O. Freytes, MD, Thomas C. Shea, MD, Tulio E. Rodriguez, MD, Ian W. Flinn, MD, PhD, Terrance Comeau, MD, FRCPC, Michael A. Pulsipher, MD, Isabelle Bence-Bruckler, MD, FRCPC, Pierre Laneuville, MD, Philip Bierman, MD, Andy I. Chen, MD, PhD, Louie H. Yu, BS, Shiva Patil, PhD, Yiping Sun, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, William Vaughan, MD
Journal: Blood
Blood (2012) 120 (21): 813.
https://doi.org/10.1182/blood.V120.21.813.813
Published: 2012
Journal Articles

A Phase I Study of DCDT2980S, an Antibody-Drug Conjugate (ADC) Targeting CD22, in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Ranjana Advani, MD, Daniel Lebovic, MD, Mark Brunvand, MD, Andy I. Chen, MD, PhD, Andre Goy, MD, Julie E. Chang, MD, Lauren S Maeda, MD, William Ho, MD, PhD, Robert Kahn, Dan Lu, Zheng Su, Yu-Waye Chu, Bruce D. Cheson, MD
Journal: Blood
Blood (2012) 120 (21): 59.
https://doi.org/10.1182/blood.V120.21.59.59
Published: 2012
Journal Articles

A Phase I/II Study of Vorinostat (SAHA), Cladribine (2-CdA), and Rituximab Shows Significant Activity in Previously Untreated Mantle Cell Lymphoma

Stephen Spurgeon, MD, Andy I Chen, MD, PhD, Craig Okada, MD, PhD, Samir Parekh, MD, Violetta V. Leshchenko, PhD, Gundula Palmbach, Bashi Ratterree, RN, Nan Subbiah, Christine Capper, RN, Elliot M Epner, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 441.
https://doi.org/10.1182/blood.V118.21.441.441
Published: 2011
Journal Articles

Improved Outcome with Busulfan, Melphalan, and Thiotepa Conditioning (BuMelTt) in Autologous Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma

Tarunpreet Bains, MD, Andy I Chen, MD, PhD, Andrew Lemieux, BS, Brandon Hayes-Lattin, MD, Jose F. Leis, MD, PhD, Richard T Maziarz, MD
Journal: Blood
Blood (2011) 118 (21): 3110.
https://doi.org/10.1182/blood.V118.21.3110.3110
Published: 2011
Journal Articles

Long Term Results of Autologous Hematopoietic Cell Transplantation (AHCT) for Peripheral T Cell Lymphoma: The Stanford Experience.

Andy I. Chen, MD, PhD, Alex McMillan, PhD, Robert S. Negrin, MD, Sandra J. Horning, MD, Ginna G. Laport, MD
Journal: Blood
Blood (2007) 110 (11): 1906.
https://doi.org/10.1182/blood.V110.11.1906.1906
Published: 2007